Home » Stocks » NURO

NeuroMetrix, Inc. (NURO)

Stock Price: $3.41 USD -0.29 (-7.84%)
Updated Mar 3, 2021 4:00 PM EST - Market closed
Market Cap 13.36M
Revenue (ttm) 7.38M
Net Income (ttm) -2.09M
Shares Out 3.78M
EPS (ttm) -0.69
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day March 3
Last Price $3.41
Previous Close $3.70
Change ($) -0.29
Change (%) -7.84%
Day's Open 3.70
Day's Range 3.39 - 3.99
Day's Volume 554,737
52-Week Range 0.81 - 6.20

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
Seeking Alpha - 1 month ago

NeuroMetrix, Inc. (NURO) CEO Dr. Shai Gozani on Q4 2020 Results - Earnings Call Transcript

GlobeNewsWire - 1 month ago

WOBURN, Mass., Jan. 28, 2021 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter and year ended December 31, 2020. The Company...

GlobeNewsWire - 1 month ago

WOBURN, Mass., Jan. 22, 2021 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it plans to issue its 2020 fourth quarter and full year financial results before the open...

Benzinga - 2 months ago

NeuroMetrix (NASDAQ: NURO) is currently up 45.17% to a price of $3.04. The stock's volume is currently 62.04 million, which is roughly 32668.92% of its recent 30-day volume average of 189.91 t...

InvestorPlace - 2 months ago

NeuroMetrix (NURO) stock is on the rise Tuesday with heavy trading despite a lack of news concerning the medical device company. The post NURO Stock: 10 Things for Potential Investors to Know ...

Seeking Alpha - 4 months ago

NeuroMetrix, Inc. (NURO) CEO Dr. Shai Gozani on Q3 2020 Results - Earnings Call Transcript

GlobeNewsWire - 4 months ago

WOBURN, Mass., Oct. 22, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter ended September 30, 2020. The Company is a le...

GlobeNewsWire - 4 months ago

WOBURN, Mass., Oct. 15, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) announced today that it plans to issue its 2020 third quarter financial results before the opening of the marke...

Seeking Alpha - 4 months ago

Who Will Win The Lucrative Autonomous Vehicles (Robotaxis) Race?

Other stocks mentioned: APTV, BMWYY, DMLRY, F, FCAU, GM, HYMTF, NSANY, TM, TSLA, VWAGY
GlobeNewsWire - 5 months ago

WOBURN, Mass., Sept. 22, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported the launch of the Quell Watch App, now available for download from the Apple App store.

GlobeNewsWire - 5 months ago

WOBURN, Mass., Sept. 21, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that the U.S. Patent and Trademark Office will issue on September 22, 2020 U.S. Patent No. ...

GlobeNewsWire - 6 months ago

WOBURN, Mass., Sept. 04, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported that it will present a scientific poster at the PAINWeek 2020 Live Virtual Conference to be ...

GlobeNewsWire - 6 months ago

WOBURN, Mass., Sept. 01, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported the publication of a large study demonstrating that DPNCheck effectively determines the seve...

GlobeNewsWire - 6 months ago

WOBURN, Mass., Aug. 20, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today announced that its Quell device will be used in an NIH-funded, multi-site randomized controlled trial ...

GlobeNewsWire - 6 months ago

WOBURN, Mass., Aug. 10, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) published an infographic on chronic knee pain ( available here ) and provided an update on how Quell technol...

Seeking Alpha - 7 months ago

NeuroMetrix's (NURO) CEO Shai Gozani on Q2 2020 Results - Earnings Call Transcript

GlobeNewsWire - 7 months ago

WOBURN, Mass., July 23, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter ended June 30, 2020. The Company is a leadi...

GlobeNewsWire - 7 months ago

WOBURN, Mass., July 16, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) announced today that it plans to issue its 2020 second quarter financial results before the opening of the ma...

GlobeNewsWire - 7 months ago

WOBURN, Mass., July 09, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today announced expanded distribution in China for DPNCheck, a fast, accurate and quantitative nerve conduct...

GlobeNewsWire - 8 months ago

WOBURN, Mass., June 25, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported that it has signed a collaboration agreement with Biomedix to comarket DPNCheck for periphera...

GlobeNewsWire - 8 months ago

WOBURN, Mass., June 10, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today announced that it has launched a marketing initiative focusing on chronic knee pain.  This effort incl...

Seeking Alpha - 10 months ago

NeuroMetrix, Inc. (NURO) CEO Shai Gozani on Q1 2020 Results - Earnings Call Transcript

GlobeNewsWire - 10 months ago

WOBURN, Mass., April 16, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today announced that Quell technology has been selected for use in a large, NIH-funded, randomized, pragmat...

GlobeNewsWire - 11 months ago

WOBURN, Mass., March 11, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today provided an update on its Quell technology commercial strategy and pipeline.

GlobeNewsWire - 11 months ago

WOBURN, Mass., March 05, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported the recent publication of three additional DPNCheck clinical studies. DPNCheck is a point-of...

Seeking Alpha - 1 year ago

NeuroMetrix, Inc. (NASDAQ:NURO) Q4 2019 Results Conference Call January 27, 2020 8:00 AM ET

GlobeNewsWire - 1 year ago

Shares of Common Stock and Certain Warrants Will Begin Trading on a Split-Adjusted Basis on November 19, 2019 Shares of Common Stock and Certain Warrants Will Begin Trading on a Split-Adjusted...

Seeking Alpha - 1 year ago

NeuroMetrix's (NURO) CEO Shai Gozani on Q3 2019 Results - Earnings Call Transcript

GlobeNewsWire - 1 year ago

WOBURN, Mass., Oct. 17, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter ended September 30, 2019.

GlobeNewsWire - 1 year ago

WOBURN, Mass., Oct. 15, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO), a health technology company that develops and commercializes products for the chronic pain and diabetes mark...

Seeking Alpha - 1 year ago

NeuroMetrix, Inc. (NURO) CEO Shai Gozani on Q2 2019 Results - Earnings Call Transcript

Zacks Investment Research - 1 year ago

NeuroMetrix (NURO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Seeking Alpha - 1 year ago

NeuroMetrix, Inc. (NURO) CEO Shai Gozani on Q1 2019 Results - Earnings Call Transcript

Zacks Investment Research - 1 year ago

NeuroMetrix (NURO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

About NURO

NeuroMetrix, a healthcare company, develops and markets products for the detection, diagnosis, and monitoring of peripheral nerve and spinal cord disorders. The company develops wearable neuro-stimulation therapeutic devices and point-of-care neuropathy diagnostic tests to address chronic health conditions, including chronic pain, sleep disorders, and diabetes. Its marketed products include Quell, a wearable device for relief of chronic intractable pain, such as nerve pain due to diabetes and lower back problems; DPNCheck, a test used to evalua... [Read more...]

Industry
Medical Instruments & Supplies
Founded
1996
CEO
Shai Gozani
Employees
20
Stock Exchange
NASDAQ
Ticker Symbol
NURO
Full Company Profile

Financial Performance

In 2020, NeuroMetrix's revenue was $7.38 million, a decrease of -20.43% compared to the previous year's $9.27 million. Losses were -$2.09 million, -44.55% less than in 2019.

Financial Statements